iX Biopharma Ltd. announced that on Feb, 06 2026 it allotted and issued 20,000 new ordinary shares after holders exercised warrants at 0.06 Singapore dollars per share.

The issuance increases the company’s total share count from 959,424,245 to 959,444,245. The new shares will rank pari passu with existing shares and are expected to begin trading on the Singapore Exchange on or around Feb, 10 2026.

To date, 4,484,800 warrants—about 7.80% of those originally issued—have been exercised. A balance of 53,024,679 warrants remains outstanding, each with an exercise price of 0.06 Singapore dollars and an expiry date of Jul, 18 2026.